<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TAPIMMUNE.xfr; Date: 2013/08/17T23:57:34 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80A30001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:tpiv="http://tapimmune.com/20130331">
    <link:schemaRef xlink:href="tpiv-20130331.xsd" xlink:type="simple" />
    <xbrli:context id="From2013-01-01to2013-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-05-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-05-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-07-27to2013-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-07-27</xbrli:startDate>
        <xbrli:endDate>2013-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-07-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-07-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-08-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-01-01to2009-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-01-01</xbrli:startDate>
        <xbrli:endDate>2009-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-08-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-02-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-04-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-04-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-06-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-06-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-07-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-07-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-07-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-07-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-07-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-08-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-08-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-10-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-10-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-10-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-11-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-01-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2013-01-01to2013-03-31">TAPIMMUNE INC</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2013-01-01to2013-03-31">0001094038</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2013-01-01to2013-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2013-01-01to2013-03-31">2013-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2013-01-01to2013-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2013-01-01to2013-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2013-01-01to2013-03-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2013-01-01to2013-03-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2013-01-01to2013-03-31">No</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2013-01-01to2013-03-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2013-01-01to2013-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2013-01-01to2013-03-31">2013</dei:DocumentFiscalYearFocus>
    <dei:EntityPublicFloat contextRef="AsOf2013-05-09" unitRef="USD" decimals="0">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2013-05-09" unitRef="Shares" decimals="INF">92728474</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:AssetsCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">151356</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">87372</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">5640149</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6129893</us-gaap:LiabilitiesCurrent>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">44456733</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">43483947</us-gaap:AdditionalPaidInCapital>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">-5488793</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-6042521</us-gaap:StockholdersEquity>
    <tpiv:DueFromGovernmentAgency contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">1099</tpiv:DueFromGovernmentAgency>
    <tpiv:DueFromGovernmentAgency contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">1077</tpiv:DueFromGovernmentAgency>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">118954</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">15004</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">26867</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">37452</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">443534</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">415998</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">462293</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">977086</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">2064171</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">1476230</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LoansPayableCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">10000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">10000</us-gaap:LoansPayableCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">153846</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">373346</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">85674</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">76404</us-gaap:CommonStockValue>
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">367405</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">352859</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">50335515</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">49894083</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">-63090</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-61648</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:Assets contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">151356</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">87372</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">1898463</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">1941716</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <tpiv:DerivativeLiabilityConversionOptionNote4 contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">329900</tpiv:DerivativeLiabilityConversionOptionNote4>
    <tpiv:DerivativeLiabilityConversionOptionNote4 contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">867575</tpiv:DerivativeLiabilityConversionOptionNote4>
    <tpiv:PromissoryNotesNote7 contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">277942</tpiv:PromissoryNotesNote7>
    <tpiv:PromissoryNotesNote7 contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">67942</tpiv:PromissoryNotesNote7>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">151356</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">87372</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Cash contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">4436</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">33839</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">250234</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf1999-07-26" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2013-03-31" unitRef="Shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2013-03-31" unitRef="Shares" decimals="INF">87571984</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">76402958</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2013-03-31" unitRef="Shares" decimals="INF">87571984</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">76402958</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2013-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">207318</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">141890</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">4136670</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InterestAndOtherIncome contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestAndOtherIncome contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestAndOtherIncome contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">33344</us-gaap:InterestAndOtherIncome>
    <us-gaap:Depreciation contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Depreciation contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Depreciation contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">213227</us-gaap:Depreciation>
    <us-gaap:ServiceManagementCosts contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">58500</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">80100</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">3132803</us-gaap:ServiceManagementCosts>
    <us-gaap:ProfessionalFees contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">266630</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">74129</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">5682739</us-gaap:ProfessionalFees>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">134380</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">115465</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">7102975</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-1115091</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-671781</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-42613634</us-gaap:OperatingIncomeLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">12533</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-7783</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">58220</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">1097168</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
    <us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">71062</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
    <us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">5401560</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-436042</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">9930</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-12126843</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfDerivatives contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfDerivatives contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfDerivatives contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">290500</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainsLossesOnSalesOfAssets contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnSalesOfAssets contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnSalesOfAssets contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-5399</us-gaap:GainsLossesOnSalesOfAssets>
    <tpiv:Consulting contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">30000</tpiv:Consulting>
    <tpiv:Consulting contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:Consulting contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">2251500</tpiv:Consulting>
    <tpiv:ConsultingStockbasedNote9 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">67812</tpiv:ConsultingStockbasedNote9>
    <tpiv:ConsultingStockbasedNote9 contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">133908</tpiv:ConsultingStockbasedNote9>
    <tpiv:ConsultingStockbasedNote9 contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">8106184</tpiv:ConsultingStockbasedNote9>
    <tpiv:InterestAndFinancingChargesNote4 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">334888</tpiv:InterestAndFinancingChargesNote4>
    <tpiv:InterestAndFinancingChargesNote4 contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">96726</tpiv:InterestAndFinancingChargesNote4>
    <tpiv:InterestAndFinancingChargesNote4 contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">6910975</tpiv:InterestAndFinancingChargesNote4>
    <tpiv:ManagementFeesStockbasedNotes8And9 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">15563</tpiv:ManagementFeesStockbasedNotes8And9>
    <tpiv:ManagementFeesStockbasedNotes8And9 contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">29563</tpiv:ManagementFeesStockbasedNotes8And9>
    <tpiv:ManagementFeesStockbasedNotes8And9 contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">4464561</tpiv:ManagementFeesStockbasedNotes8And9>
    <tpiv:ResearchAndDevelopmentStockbased contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:ResearchAndDevelopmentStockbased contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:ResearchAndDevelopmentStockbased contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">612000</tpiv:ResearchAndDevelopmentStockbased>
    <tpiv:LossOnDebtFinancingNote5 contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:LossOnDebtFinancingNote5 contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:LossOnDebtFinancingNote5 contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-1373263</tpiv:LossOnDebtFinancingNote5>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-441432</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-598572</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-50335515</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-01-01to2013-03-31" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2012-01-01to2012-03-31" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2013-01-01to2013-03-31" unitRef="Shares" decimals="INF">80694680</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2012-01-01to2012-03-31" unitRef="Shares" decimals="INF">52470198</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">425051</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">105900</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">16697160</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:GainsLossesOnRestructuringOfDebt contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnRestructuringOfDebt contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnRestructuringOfDebt contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-1373263</us-gaap:GainsLossesOnRestructuringOfDebt>
    <us-gaap:GainLossOnSaleOfDebtInvestments contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-436042</us-gaap:GainLossOnSaleOfDebtInvestments>
    <us-gaap:GainLossOnSaleOfDebtInvestments contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">9930</us-gaap:GainLossOnSaleOfDebtInvestments>
    <us-gaap:GainLossOnSaleOfDebtInvestments contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-12126843</us-gaap:GainLossOnSaleOfDebtInvestments>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-5399</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherNoncashExpense contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNoncashExpense contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">96726</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">5468499</us-gaap:OtherNoncashExpense>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">83375</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">163471</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">13198995</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInContractReceivablesNet contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInContractReceivablesNet contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">24</us-gaap:IncreaseDecreaseInContractReceivablesNet>
    <us-gaap:IncreaseDecreaseInContractReceivablesNet contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">1055</us-gaap:IncreaseDecreaseInContractReceivablesNet>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">103950</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-15152</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">142954</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInDeferredCharges contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-10585</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInDeferredCharges contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-3827</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInDeferredCharges contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">1618</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">630558</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">24268</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">6227839</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">27536</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">43761</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">661665</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-454454</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-332383</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-16897471</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">235951</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">85000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">11096526</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">2123906</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromShortTermDebt contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">428000</us-gaap:ProceedsFromShortTermDebt>
    <tpiv:ProceedsFromShortTermBankLoansAndNotesPayable contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:ProceedsFromShortTermBankLoansAndNotesPayable contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:ProceedsFromShortTermBankLoansAndNotesPayable contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">919845</tpiv:ProceedsFromShortTermBankLoansAndNotesPayable>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">140000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">218626</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAcquiredFromAcquisition contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">423373</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">204747</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-29403</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-226483</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">4436</us-gaap:CashPeriodIncreaseDecrease>
    <tpiv:Depreciation1 contextRef="From2013-01-01to2013-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:Depreciation1 contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <tpiv:Depreciation1 contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">213228</tpiv:Depreciation1>
    <tpiv:AdvancesFromRelatedParties contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">80500</tpiv:AdvancesFromRelatedParties>
    <tpiv:AdvancesFromRelatedParties contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">20900</tpiv:AdvancesFromRelatedParties>
    <tpiv:AdvancesFromRelatedParties contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">1880283</tpiv:AdvancesFromRelatedParties>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">108600</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2012-01-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromWarrantExercises contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">108600</us-gaap:ProceedsFromWarrantExercises>
    <tpiv:CashEndOfPeriodperiod contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">4436</tpiv:CashEndOfPeriodperiod>
    <tpiv:CashEndOfPeriodperiod contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">23751</tpiv:CashEndOfPeriodperiod>
    <tpiv:CashEndOfPeriodperiod contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">4436</tpiv:CashEndOfPeriodperiod>
    <us-gaap:NatureOfOperations contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 1:&amp;#9;Nature&#13;of Operations&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;TapImmune Inc. (the &amp;#147;Company&amp;#148;),&#13;a Nevada corporation incorporated in 1992, is a clinical development stage company which was formed for the purpose of building&#13;a biotechnology business specializing in the discovery and development of immunotherapeutics aimed at the treatment of cancer,&#13;and therapies for infectious diseases, autoimmune disorders and transplant tissue rejection.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Since inception, the Company has been&#13;party to various Collaborative Research Agreements (&amp;#147;CRA&amp;#148;) working with universities to carry out development of the&#13;licensed technology and providing TapImmune the option to acquire the rights to commercialize any additional technologies developed&#13;within the CRA. The lead product candidate, a set of Class II HER2/neu antigens is in Phase I clinical trials in breast cancer&#13;patients at the Mayo Clinic. This product will be combined with a novel Class I HER2/neu antigen in further clinical trials and&#13;with TapImmune&amp;#146;s expression vector technology containing TAP in a &amp;#147;boost&amp;#148; strategy. TapImmune has a license and&#13;an exclusive option to license the HER2/neu antigen technologies from the Mayo Clinic. The TAP technology is now wholly owned and&#13;with no ongoing license or royalty, resulting from these license agreements is an immunotherapy vaccine, on which the Company has&#13;been completing pre-clinical work in anticipation of clinical trials. Specifically, the Company has obtained and expanded on three&#13;U.S. and international patents, tested various viral vectors, licensed a viral vector and is working towards production of a clinical&#13;grade vaccine. The Company plans to continue development of the lead product vaccine through to clinical trials in both oncology&#13;and infectious diseases alone or in partnership with other vaccine developers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;These&#13;consolidated financial statements have been prepared on the basis of a going concern which contemplates the realization of assets&#13;and the satisfaction of liabilities in the normal course of business. As at March 31, 2013, the Company had a working capital deficiency&#13;of $5,488,793 and has incurred significant losses since inception. Further losses are anticipated in the development stage raising&#13;substantial doubt as to the Company&amp;#146;s ability to continue as a going concern. The ability of the Company to continue as a&#13;going concern is dependent on raising additional capital to fund ongoing research and development, maintenance and protection of&#13;patents, accommodation from certain debt obligations and ultimately on generating future profitable operations. Planned expenditures&#13;relating to future clinical trials of the Company&amp;#146;s immunotherapy vaccine will require significant additional funding. The&#13;Company is dependent on future financings to fund ongoing research and development as well as working capital requirements. The&#13;Company&amp;#146;s future capital requirements will depend on many factors including the rate and extent of scientific progress in&#13;its research and development programs, the timing, cost and scope involved in clinical trials, obtaining regulatory approvals,&#13;pursuing further patent protections and the timing and costs of commercialization activities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;Management&#13;is addressing going concern remediation through seeking new sources of capital, restructuring and retiring debt through conversion&#13;to equity and debt settlement arrangements with creditors, cost reduction programs and seeking possible joint venture participation.&#13;Management&amp;#146;s plans are intended to return the Company to financial stability and improve continuing operations. The Company&#13;is continuing initiatives to raise capital through private placements, related party loans and other institutional sources to meet&#13;immediate working capital requirements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;Additional&#13;funding was raised through equity and debt placements in 2013 and 2012, and management intends to continue restructuring outstanding&#13;debt and equity instruments. Additional capital is required currently to expand programs including pre-clinical work and to establish&#13;future manufacturing contracts necessary for clinical trials for the lead TAP (Transporters of Antigen Processing) vaccine and&#13;infectious disease adjuvant technology. Strategic partnerships will be needed to continue the product development portfolio and&#13;fund development costs. These measures, if successful, may contribute to reduce the risk of going concern uncertainties for the&#13;Company over the next twelve months. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;There is no certainty that&#13;the Company will be able to arrange sufficient funding to satisfy current debt obligations or to continue development of products&#13;to marketability.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 2:&amp;#9;UNAUDITED&#13;CONSOLIDATED FINANCIAL STATEMENTS FOR AN INTERIM PERIOD&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"&gt;Basis of Presentation&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In the opinion of management, the accompanying&#13;balance sheets and related interim statements of operations and cash flows include all adjustments, consisting only of normal recurring&#13;items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of&#13;America (&amp;#147;U.S. GAAP&amp;#148;). Preparing financial statements requires management to make estimates and assumptions that affect&#13;the reported amounts of assets, liabilities, and expenses. Significant areas requiring management&amp;#146;s estimates and assumptions&#13;include deferred taxes and related tax balances and disclosures, determining the fair value of stock-based compensation and stock&#13;based transactions, the fair value of the components of the convertible notes payable, foreign exchange gains and losses, allocation&#13;of costs to research and development and accrued liabilities. Matters impacting the company&amp;#146;s ability to continue as a going&#13;concern and contingencies also involve the use of estimates and assumptions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Interim results are not necessarily indicative&#13;of results for a full year. The information included in this quarterly report on Form 10-Q should be read in conjunction with information&#13;included in the Company&amp;#146;s annual report on Form 10-K filed on May 15, 2013, with the U.S. Securities and Exchange Commission.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"&gt;Basis of Presentation&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In the opinion of management, the accompanying&#13;balance sheets and related interim statements of operations and cash flows include all adjustments, consisting only of normal recurring&#13;items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of&#13;America (&amp;#147;U.S. GAAP&amp;#148;). Preparing financial statements requires management to make estimates and assumptions that affect&#13;the reported amounts of assets, liabilities, and expenses. Significant areas requiring management&amp;#146;s estimates and assumptions&#13;include deferred taxes and related tax balances and disclosures, determining the fair value of stock-based compensation and stock&#13;based transactions, the fair value of the components of the convertible notes payable, foreign exchange gains and losses, allocation&#13;of costs to research and development and accrued liabilities. Matters impacting the company&amp;#146;s ability to continue as a going&#13;concern and contingencies also involve the use of estimates and assumptions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Interim results are not necessarily indicative&#13;of results for a full year. The information included in this quarterly report on Form 10-Q should be read in conjunction with information&#13;included in the Company&amp;#146;s annual report on Form 10-K filed on May 15, 2013, with the U.S. Securities and Exchange Commission.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 3:&amp;#9;Research&#13;Agreements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Crucell Holland B.V. (&amp;#147;Crucell&amp;#148;)&#13;&amp;#150; Research License and Option Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Effective August 7, 2003, Crucell and&#13;the Company&amp;#146;s subsidiary GPI entered into a five-year research license and option agreement whereby Crucell granted to GPI&#13;a non-exclusive worldwide license for the research use of its adenovirus technology. The Company was required to make certain payments&#13;over the five-year term totaling Euro &amp;#128;450,000 (approximately $510,100).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;At December 31, 2008, $243,598 (&amp;#128;172,801)&#13;was owing to Crucell under this agreement. During the year ended December 31, 2009, management negotiated a settlement of the outstanding&#13;balance requiring a &amp;#128;17,000 cash payment (paid) and the issuance of 265,000 shares of the Company&amp;#146;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In addition, retroactively effective&#13;August 7, 2008, the Company negotiated an amended license agreement for the use of Crucell&amp;#146;s adenovirus technology. The Company&#13;is required to make annual license payments on the anniversary of the effective date for the three year term equal to &amp;#128;75,000&#13;per annum. As at March 31, 2013, the Company had accrued $443,535 (&amp;#128;345,957) under the amended agreement, inclusive of interest&#13;on outstanding amounts. The Company is currently delinquent on making its first annual license payment under the amended license&#13;agreement. Crucell has the right to cancel the agreement however, to date, the Company has not received any notice terminating&#13;the license agreement. Management plans to negotiate an amended payment structure with Crucell that, if successful, would allow&#13;the Company to maintain the license agreement in good standing. However, there is no certainty that the license agreement will&#13;be maintained or that Management will successfully negotiate new terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Mayo Clinic &amp;#150;License&#13;Option Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0"&gt;For details regarding the license option agreement with Mayo Clinic, please refer to Note 11.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock>
    <tpiv:CededPremiumsWrittenPropertyAndCasualty1 contextRef="AsOf2003-08-07" unitRef="USD" decimals="0">510100</tpiv:CededPremiumsWrittenPropertyAndCasualty1>
    <tpiv:OwingToCrucellAmount contextRef="AsOf2008-12-31" unitRef="USD" decimals="0">243598</tpiv:OwingToCrucellAmount>
    <tpiv:CashPaymentPaid contextRef="From2009-01-01to2009-12-31" unitRef="USD" decimals="0">17000</tpiv:CashPaymentPaid>
    <tpiv:SharesIssuance contextRef="From2009-01-01to2009-12-31" unitRef="Shares" decimals="INF">265000</tpiv:SharesIssuance>
    <tpiv:AnnualLicensePayments contextRef="AsOf2008-08-07" unitRef="USD" decimals="0">75000</tpiv:AnnualLicensePayments>
    <tpiv:AccruedAmount contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">443535</tpiv:AccruedAmount>
    <us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 4:&amp;#9;DERIVATIVE&#13;WARRANT LIABILITY AND FAIR VALUE&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The Company has evaluated the application&#13;ASC 480-10 &lt;i&gt;Distinguishing liabilities from equity&lt;/i&gt;, ASC 815-40 &lt;i&gt;Contracts in an Entity&amp;#146;s Own Equity&lt;/i&gt; and ASC 718-10&#13;&lt;i&gt;Compensation &amp;#150; Stock Compensation&lt;/i&gt; to the issued and outstanding warrants to purchase common stock that were issued&#13;with the convertible notes, private placements, consulting agreements, and various debt settlements during 2009 through 2012. Based&#13;on the guidance, management concluded these instruments are required to be accounted for as derivatives either due to a ratchet&#13;down protection feature available on the exercise price (Note 5) or a holder&amp;#146;s right to put the warrants back to the Company&#13;for cash under certain conditions or a conversion option feature with conversion into variable number of shares. Under ASC 815-40-25,&#13;the Company records the fair value of these warrants and conversion options (derivatives) on its balance sheet, at fair value,&#13;with changes in the values reflected in the statements of operations as &amp;#147;Changes in fair value of derivative liabilities&amp;#148;.&#13;The fair value of the share purchase warrants are recorded on the balance sheet under &amp;#145;Derivative liability &amp;#150; warrants&amp;#146;&#13;and the fair value of the conversion options are recorded on the balance sheet under &amp;#145;Derivative liability &amp;#150; conversion&#13;option&amp;#146;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;ASC 820-10 defines fair value as the&#13;exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous&#13;market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also&#13;establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable&#13;inputs when measuring fair value. ASC 820-10 describes three levels of inputs that may be used to measure fair value: Level 1 &amp;#150;&#13;Quoted prices in active markets for identical assets or liabilities; Level 2 &amp;#150; Observable inputs other than Level 1 prices,&#13;such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable&#13;market data for substantially the full term of the assets or liabilities; and Level 3 &amp;#150; Unobservable inputs that are supported&#13;by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted&#13;cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant&#13;judgment or estimation. The Company&amp;#146;s Level 3 liabilities consist of the derivative liabilities associated with the warrants&#13;issued with the convertible notes during the year ended December 31, 2011. At December 31, 2012, all of the Company&amp;#146;s derivative&#13;liabilities were categorized as Level 3 fair value liabilities. If the inputs used to measure the financial assets and liabilities&#13;fall within more than one level described above, the categorization is based on the lowest level input that is significant to the&#13;fair value measurement of the instrument.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;i&gt;Level 3 Valuation Techniques&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Financial liabilities are considered&#13;Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and&#13;at least one significant model assumption or input is unobservable. Level 3 financial liabilities consist of the notes and warrants&#13;for which there is no current market for these securities such that the determination of fair value requires significant judgment&#13;or estimation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Determining fair value of share purchase&#13;warrants and conversion options, given the Company&amp;#146;s stage of development and financial position, is highly subjective and&#13;identifying appropriate measurement criteria and models is subject to uncertainty. There are several generally accepted pricing&#13;models for warrants and options and derivative provisions. The Company has chosen to value the warrants and conversion option on&#13;the notes that contain ratchet down provisions using the Binomial model under the following assumptions:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;December 31, 2012&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;March 31, 2013&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 26%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Share purchase warrants&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.08 to 3.78&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.02% to 0.36%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;199%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.01 to 3.53&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.04% to 0.36%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;199%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;December 31, 2012&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;March 31, 2013&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 21%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 12%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Conversion Option&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.003 to 0.89&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.05% to 0.19%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;100.88% to 141.21%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.049 to 0.64&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.04% to 0.17%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;108.00% to 123.76%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The foregoing assumptions are reviewed&#13;quarterly and are subject to change based primarily on management&amp;#146;s assessment of the probability of the events described&#13;occurring. Accordingly, changes to these assessments could materially affect the valuations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;i&gt;Financial Assets and Liabilities Measured&#13;at Fair Value on a Recurring Basis&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Financial assets and liabilities measured&#13;at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability &amp;#150; warrants&#13;and Derivative liability &amp;#150; conversion option:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;As of March 31, 2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Fair Value Measurements&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 41%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of December 31, 2012 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Fair Value Measurements Using&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: -12.25pt; padding-left: 5.4pt"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 37%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The table below provides a summary of the changes&#13;in fair value, including net transfers, in and/or out, of financial assets and liabilities measured at fair value on a recurring&#13;basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2013 and the year ended December&#13;31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using Level 3 Inputs&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance,&amp;#160; December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 1,317,834&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ -&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 1,317,834&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions during the year&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;300,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;737,700&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,037,700&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total unrealized (gains) or losses included in net loss&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(597,127)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;129,875&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(467,252)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Debt settlement&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(43,621)&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(43,621)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Transfers in and/or out of Level 3&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance,&amp;#160; December 31, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;977,086&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,844,661&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions during the year&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;44,700&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;44,700&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total unrealized (gains) or losses included in net loss&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(514,793)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(582,375)&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(1,097,168)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Transfers in and/or out of Level 3&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 37%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 329,900&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the warrants is determined&#13;using a Binomial option pricing model. The valuation of warrants is subjective and is affected by changes in inputs to the valuation&#13;model including the price per share of common stock, the historical volatility of the stock price, risk-free rates based on U.S.&#13;Treasury security yields, the expected term of the warrants and dividend yield. Changes in these assumptions can materially affect&#13;the fair value estimate. The Company could ultimately incur amounts to settle the warrant at a cash settlement value that is significantly&#13;different than the carrying value of the liability on the financial statements. The Company will continue to classify the fair&#13;value of the warrants as a liability until the warrants are exercised, expire, or are amended in a way that would no longer require&#13;these warrants to be classified as a liability. Changes in the fair value of the common stock warrants liability are recognized&#13;as a component of other income (expense) in the statement of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The net cash settlement value at the&#13;time of any future Fundamental Transaction will depend upon the value of the following inputs at that time: the consideration value&#13;per share of the Company&amp;#146;s common stock, the volatility of the Company&amp;#146;s common stock, the remaining term of the warrant&#13;from announcement date, the risk-free interest rate based on U.S. Treasury security yields, and the Company&amp;#146;s dividend yield.&#13;The warrant requires use of a volatility assumption equal to the greater of 100% and the 100-day volatility function determined&#13;as of the trading day immediately following announcement of a Fundamental Transaction. The fair value of the warrants is determined&#13;using the Black Scholes Option Pricing Model.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock>
    <us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;December 31, 2012&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;March 31, 2013&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 26%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Share purchase warrants&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.08 to 3.78&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.02% to 0.36%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;199%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.01 to 3.53&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.04% to 0.36%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;199%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PurchaseCommitmentExcludingLongtermCommitmentTableTextBlock>
    <us-gaap:DisclosureOfCreditDerivativesTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;December 31, 2012&lt;/td&gt;&#13;    &lt;td colspan="4" style="border-bottom: windowtext 1pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;March 31, 2013&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 21%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 12%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Expected Life (Years)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Risk free Rate&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Dividend yield&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 10%; border-bottom: windowtext 1.5pt solid; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Volatility&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Conversion Option&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.003 to 0.89&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.05% to 0.19%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;100.88% to 141.21%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.049 to 0.64&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.04% to 0.17%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;0.00%&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;108.00% to 123.76%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DisclosureOfCreditDerivativesTextBlock>
    <us-gaap:DerivativesAndFairValueTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;As of March 31, 2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Fair Value Measurements&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;329,900&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 41%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of December 31, 2012 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Fair Value Measurements Using&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 977,086&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: -12.25pt; padding-left: 5.4pt"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,844,661&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 37%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:TransfersAndServicingOfFinancialAssetsServicingOfFinancialAssetsPolicy contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using Level 3 Inputs&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 4pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Derivative liability - warrants&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Derivative liability &amp;#150; conversion option&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance,&amp;#160; December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 1,317,834&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ -&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 1,317,834&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions during the year&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;300,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;737,700&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,037,700&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total unrealized (gains) or losses included in net loss&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(597,127)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;129,875&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(467,252)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Debt settlement&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(43,621)&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(43,621)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Transfers in and/or out of Level 3&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance,&amp;#160; December 31, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;977,086&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;867,575&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,844,661&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions during the year&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;44,700&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;44,700&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Total unrealized (gains) or losses included in net loss&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(514,793)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(582,375)&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(1,097,168)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Transfers in and/or out of Level 3&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 37%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 462,293&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 329,900&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 792,193&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:TransfersAndServicingOfFinancialAssetsServicingOfFinancialAssetsPolicy>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 5:&amp;#9;CONVERTIBLE&#13;NOTES PAYABLE&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;The&#13;following is a summary of debt instrument transactions that are relevant to the current year:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Face Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Principal Repayment/&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Settlement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Unamortized&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Note&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Discount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Balance at&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;February 2011 Secured Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due February 24, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,184,694&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 203,836&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160; 120,496&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 860,362&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;April 2011 Secured Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due April 4, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;215,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;34,681&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;180,319&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;June 2011 Secured Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due June 6, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;30,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,271&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;26,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 8, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due August 8, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;111,430&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;65,970&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,193&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;29,267&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 12, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note became due November 12, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 20, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due August 20, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;20,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;7,780&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;12,220&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;September 18, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due October 1, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;82,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;61,750&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;10,072&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;10,678&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;October 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due October 15, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;340,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;184,438&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;155,562&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;&lt;b&gt;October 9, 2012 Convertible Notes&lt;/b&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;100,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;100,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;November 1, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due April 30, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;31,471&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;15,000&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2,381&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;14,090&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;November 20, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due November 20, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;55,710&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;35,715&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,995&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;December 14, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due April 18, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;189,210&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;189,210&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;December 18, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due December 14, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;50,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;50,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;January 5, 2013 Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;567,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;567,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;February 27, 2013 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due February 27, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;55,710&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;45,990&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;9,720&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 3,060,954&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 535,766&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160; 461,017&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 2,064,171&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;February 2011 Secured Convertible Notes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On February 24, 2011, the Company entered&#13;into a securities purchase agreement with accredited investors to place Senior Secured Convertible Notes (the &amp;#147;February 2011&#13;Notes&amp;#148;) with a maturity date of three years after the issuance thereof in the aggregate principal amount of $1,184,694. Consideration&#13;under the notes consisted of $944,694 in cash proceeds, including accrued interest, and $240,000 was subscribed for by two of the&#13;holders of outstanding and demandable 2010 secured convertible notes (the &amp;#147;2010 Notes&amp;#148;). The holders of the 2010 Notes&#13;returned their Series A, Series B and Series C warrants to the Company for cancellation. In connection with the issuance of the&#13;February 2011 Notes, the Company entered into a 2011 Security Agreement with the note holders securing the February 2011 Notes&#13;with all of the Company&amp;#146;s assets. One year after the issuance of the February 2011 Notes, the note holders have the option&#13;to convert a portion or all of the outstanding balance of the February 2011 Notes including any accrued interest into shares of&#13;the Company&amp;#146;s common stock at a conversion rate of $0.15 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The February 2011 Notes bear interest&#13;at the rate of 10% per annum except in case of default, in which case they bear interest at the rate of 20% per annum. The interest&#13;is due on the February 2011 Notes at the end of each three month period, starting three months from their issuance. One year after&#13;the issuance of the February 2011 Notes, the Company may elect to prepay a portion of the principal. If the Company makes such&#13;an election, the holders may elect to receive such prepayment in cash or in shares of the Company&amp;#146;s common stock, at a conversion&#13;rate of $0.15 per share, or in a combination thereof.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The Company paid a finders&amp;#146; fee&#13;of $41,500. The finder&amp;#146;s fee was accounted for as deferred financing costs, and is being amortized over the term of the notes.&#13;At March 31, 2013, $11,597 of the $26,867 in deferred financing costs relates to the February 2011 Notes which remains unamortized,&#13;and is presented in the current assets on the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In connection with the issuance of the&#13;February 2011 Notes, the Company issued 2,369,388 warrants, exercisable into common stock at $0.25 with five year terms. The Company&#13;may force the exercise of the warrants at any time that the average volume weighted average price of the Company&amp;#146;s common&#13;stock over the prior ten trading days is greater than $0.50, the average daily dollar volume of the Company&amp;#146;s common stock&#13;sold over those ten trading days is greater than $25,000 and there is an effective registration statement covering the resale of&#13;the shares underlying the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the warrants based on the calculated fair value at the date of issuance. The fair value of the warrants was recorded at $483,355&#13;and recognized as derivative liabilities and the debt was recorded at $701,339. The fair value of the warrants was calculated using&#13;the Binomial option pricing model under the following assumptions: estimated life of five years, risk free rate of 2.06%, dividend&#13;yield of 0% and volatility of 199%. The debt discount is being accreted over the three year term of the February 2011 Notes using&#13;the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the year ended December 31, 2012,&#13;one of the investors settled the principal amount of $203,836 and accrued interest of $16,419 of the February 2011 Notes in exchange&#13;for December 14, 2012 Convertible Note (the &amp;#147;December 14, 2012 Note&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $32,862 was recorded for the February 2011 Notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;April 2011 Secured Convertible Notes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On April 4, 2011, the Company entered&#13;into a securities purchase agreement with accredited investors to place Senior Secured Convertible Notes (the &amp;#147;April 2011&#13;Notes&amp;#148;) with a maturity date of three years after the issuance thereof in the aggregate principal amount of $215,000. Consideration&#13;under the notes consisted of $190,000 in cash proceeds, and $25,000 was subscribed for by a holder of 2010 Notes in exchange for&#13;the extinguishment of the Series A, Series B and Series C warrants related to the 2010 Notes. In connection with the issuance of&#13;the April 2011 Notes, the Company entered into a 2011 Security Agreement with the note holders securing the April 2011 Notes with&#13;a secondary security interest in all of the Company&amp;#146;s assets. One year after the issuance of the April 2011 Notes, the note&#13;holders have the option to convert a portion or all of the outstanding balance of the April 2011 Notes including any accrued interest&#13;into shares of the Company&amp;#146;s common stock at a conversion rate of $0.15 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The April 2011 Notes bear interest at&#13;the rate of 10% per annum except in case of default, in which case they bear interest at the rate of 20% per annum. The interest&#13;is due on the April 2011 Notes at the end of each three month period, starting three months from their issuance. One year after&#13;the issuance of the April 2011 Notes, the Company may elect to prepay a portion of the principal. If the Company makes such an&#13;election, the holders may elect to receive such prepayment in cash or in shares of the Company&amp;#146;s common stock, at a conversion&#13;rate of $0.15 per share, or in a combination thereof.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The Company paid a finders&amp;#146; fee&#13;of $4,550. The finder&amp;#146;s fee was accounted for as deferred financing costs, and is being amortized over the term of the notes.&#13;At March 31, 2013, $1,517 of the $26,867 in deferred financing costs relates to the April 2011 Notes which remains unamortized,&#13;and is presented in the current assets on the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In connection with the issuance of the&#13;April 2011 Notes, the Company issued 430,000 warrants, exercisable into common stock at $0.25 with 2 year terms. The Company may&#13;force the exercise of the warrants at any time that the average volume weighted average price of the Company&amp;#146;s common stock&#13;over the prior ten trading days is greater than $0.50, the average daily dollar volume of the Company&amp;#146;s common stock sold&#13;over those ten trading days is greater than $25,000 and there is an effective registration statement covering the resale of the&#13;shares underlying the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the warrants based on the calculated fair value. The fair value of the warrants was recorded at $130,720 and recognized as derivative&#13;liabilities and the debt was recorded at $84,280. The fair value of the warrants was calculated using the Binomial option pricing&#13;model under the following assumptions: estimated life of two years, risk free rate of 0.77%, dividend yield of 0% and volatility&#13;of 199%. The debt discount is being accreted over the three year term of the April 2011 Notes using the effective interest rate&#13;method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $8,459 was recorded for the April 2011 Notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;June 2011 Secured Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On June 6, 2011, the Company entered&#13;into a securities purchase agreement with accredited investors to place Senior Secured Convertible Note (the &amp;#147;June 2011 Note&amp;#148;)&#13;with a maturity date of three years after the issuance thereof in the aggregate principal amount of $30,000. In connection with&#13;the issuance of the June 2011 Note, the Company entered into a 2011 Security Agreement with the note holder securing the June 2011&#13;Note with a secondary security interest in all of the Company&amp;#146;s assets. One year after the issuance of the June 2011 Note,&#13;the note holder has the option to convert a portion or all of the outstanding balance of the June 2011 Note including any accrued&#13;interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.15 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The June 2011 Note bears interest at&#13;the rate of 10% per annum except in case of default, in which case it bears interest at the rate of 20% per annum. The interest&#13;is due on the June 2011 Note at the end of each three month period, starting three months from its issuance. One year after the&#13;issuance of the June 2011 Note, the Company may elect to prepay a portion of the principal. If the Company makes such an election,&#13;the holders may elect to receive such prepayment in cash or in shares of the Company&amp;#146;s common stock, at a conversion rate&#13;of $0.15 per share, or in a combination thereof.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In connection with the issuance of the&#13;June 2011 Note, the Company issued 60,000 warrants, exercisable into common stock at $0.25 with two year terms. The Company may&#13;force the exercise of the warrants at any time that the average volume weighted average price of the Company&amp;#146;s common stock&#13;over the prior ten trading days is greater than $0.50, the average daily dollar volume of the Company&amp;#146;s common stock sold&#13;over those ten trading days is greater than $25,000 and there is an effective registration statement covering the resale of the&#13;shares underlying the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the warrants based on the calculated fair value. The fair value of the warrants was recorded at $8,280 and recognized as derivative&#13;liabilities and the debt was recorded at $21,720. The fair value of the warrants was calculated using the Binomial option pricing&#13;model under the following assumptions: estimated life of two years, risk free rate of 0.43%, dividend yield of 0% and volatility&#13;of 199%. The debt discount is being accreted over the three year term of the June 2011 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $682 was recorded for the June 2011 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;August 8, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On August 8, 2012, the Company entered&#13;into a securities purchase agreement with an accredited investor to place a Convertible Note (the &amp;#147;August 8, 2012 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $111,430. Consideration under&#13;the notes consisted of $92,000 in cash proceeds after $8,000 payment of finders&amp;#146; fee and an original issue discount of $11,430.&#13;The note holder has the option to convert a portion or all of the outstanding balance of the August 8, 2012 Note including any&#13;accrued interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 70% of the lowest traded&#13;price in the 25 trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The August 8, 2012 Note carries no interest&#13;if the Company repays the note within 90 days from issuance. If the Company does not repay the note within 90 days, a one-time&#13;interest of 5% shall apply to the principal sum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The finder&amp;#146;s fee of $8,000 was&#13;accounted for as deferred financing costs, and is being amortized over the term of the note. At March 31, 2013, $1,360 of the $26,867&#13;in deferred financing costs relates to the August 8, 2012 Note which remains unamortized, and is presented in current assets on&#13;the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $155,700 and&#13;recognized as a derivative liability and the debt was recorded at $nil. The transaction resulted in an accounting loss on debt&#13;financing of $55,700. The fair value of the conversion option was calculated using the Binomial option pricing model under the&#13;following assumptions: estimated life of one year, risk free rate of 0.19%, dividend yield of 0% and volatility of 139.77%. The&#13;debt discount is being accreted over the one year term of the August 8, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the three months ended March 31,&#13;2013, the investor converted $65,970 and accrued interest of the August 8, 2012 Note into common shares (Note 9). The balance remaining&#13;on the August 8, 2012 Note as on March 31, 2013 was $45,460.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $11,209 was recorded for the August 8, 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;August 12, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On August 12, 2012, the Company entered&#13;into a securities purchase agreement with accredited investors to place a Convertible Note (the &amp;#147;August 12, 2012 Note&amp;#148;)&#13;with a maturity date of three months after the issuance thereof in the aggregate principal amount of $27,500. Consideration under&#13;the notes consisted of $25,000 in cash proceeds after an original issue discount of $2,500. The note holder has the option to convert&#13;a portion or all of the outstanding balance of the August 8, 2012 Note including any accrued interest into shares of the Company&amp;#146;s&#13;common stock at a conversion rate of $0.09 per share or on similar terms as of any future financings with more favorable terms.&#13;The agreement provides for the Company to issue 50,000 shares to the note holder as risk premium. The 50,000 shares were valued&#13;at $6,250 and recorded as loss on debt financing and obligation to issue shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The August 12, 2012 Note bears interest&#13;at the rate of 10% per annum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $31,100 and&#13;recognized as a derivative liability and the debt was recorded at $nil. The transaction resulted in an accounting loss on debt&#13;financing of $6,100. The fair value of the conversion option was calculated using the Binomial option pricing model under the following&#13;assumptions: estimated life of three months, risk free rate of 0.11%, dividend yield of 0% and volatility of 138.31%. The debt&#13;discount is being accreted over the three month term of the August 12, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The Company has not repaid the August&#13;12, 2012 Note as of March 31, 2013, which is in default.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;August 20, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On August 20, 2012, the Company entered&#13;into a securities purchase agreement with accredited investors to place a Convertible Note (the &amp;#147;August 20, 2012 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $20,000. The note holder has the&#13;option to convert a portion or all of the outstanding balance of the August 8, 2012 Note including any accrued interest into shares&#13;of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 70% of the lowest traded price in the 25 trading&#13;days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The August 20, 2012 Note bears interest&#13;at the rate of 8% per annum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $36,100 and&#13;recognized as a derivative liability and the debt was recorded at $nil. The transaction resulted in an accounting loss on debt&#13;financing of $16,100. The fair value of the conversion option was calculated using the Binomial option pricing model under the&#13;following assumptions: estimated life of one year, risk free rate of 0.19%, dividend yield of 0% and volatility of 140.11%. The&#13;debt discount is being accreted over the one year term of the August 20, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;For the three months ended March 31,&#13;2013, accretion of the debt discount of $4,932 was recorded for the August 20, 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;September 18, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On September 18, 2012, the Company entered&#13;into a securities purchase agreement with accredited investors to place a Convertible Note (the &amp;#147;September 18, 2012 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $82,500. Consideration under the&#13;notes consisted of $69,000 in cash proceeds after $6,000 payment of finders&amp;#146; fee and an original issue discount of $7,500.&#13;The note holder has the option to convert a portion or all of the outstanding balance of the September 18, 2012 Note including&#13;any accrued interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 70% of the lowest&#13;traded price in the 20 trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The September 18, 2012 Note carries no&#13;interest other than the amortization of the original issue discount.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The finder&amp;#146;s fee of $6,000 was&#13;accounted for as deferred financing costs, and is being amortized over the term of the note. At March 31, 2013, $755 of the $26,867&#13;in deferred financing costs relates to the September, 2012 Note which remains unamortized, and is presented in current assets on&#13;the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $76,400 and&#13;recognized as a derivative liability and the debt was recorded at $nil. The transaction resulted in an accounting loss on debt&#13;financing of $1,400. The fair value of the conversion option was calculated using the Binomial option pricing model under the following&#13;assumptions: estimated life of one year, risk free rate of 0.20%, dividend yield of 0% and volatility of 141.43%. The debt discount&#13;is being accreted over the one year term of the September, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the three months ended March 31,&#13;2013, the investor converted $61,750 and accrued interest of the September 18, 2012 Note into common shares (Note 9). The balance&#13;remaining on the September 18, 2012 Note as on March 31, 2013 was $20,750.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $4,954 was recorded for the September, 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;October 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On October 15, 2012, the Company entered&#13;into a securities purchase agreement with an accredited investor to place a Convertible Note (the &amp;#147;October 2012 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $340,000. Consideration under&#13;the notes consisted of $310,000 in cash proceeds after $10,000 payment of legal fee and an original issue discount of $30,000.&#13;The note holder has the option to convert a portion or all of the outstanding balance of the October 2012 Note including any accrued&#13;interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.12 per share or to a new lower issuance price&#13;if the Company issues shares (or reduces the conversion or exercise price for outstanding debt or warrants) for less than $0.12.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The October 2012 Note carries an interest&#13;rate of 8%. There are seven installment payments due on the note beginning on the seventh month after its issuance and each month&#13;thereafter until maturity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The legal fee of $10,000 was accounted&#13;for as deferred financing costs, and is being amortized over the term of the note. At March 31, 20132, $5,425 of the $26,867 in&#13;deferred financing costs relates to the October 2012 Note which remains unamortized, and is presented in current assets on the&#13;Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;Provided that there is sufficient volume&#13;in the trading of the Company&amp;#146;s common stock and other criteria are met, the Company may elect to make any payment due on&#13;an installment date in shares of common stock. If the Company elects to make a payment in shares of common stock, the number of&#13;shares that the Company issues will be equal to the amount to be converted divided by the lesser of the conversion price or 70%&#13;of the average of the three lowest closing bid prices of the shares of common stock during the prior twenty consecutive trading&#13;days. If the Company elects to pay the full amount of the note in common shares (excluding any interest that becomes due thereon),&#13;the holder shall receive at a minimum 2,833,333 shares of the Company&amp;#146;s common stock, but this amount could be substantially&#13;higher. Unless otherwise agreed in writing by both parties, at no time will the holder convert any amount of the debenture into&#13;common stock that would result in the holder owning more than 4.99% of the common stock outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;As part of the agreement, the Company&#13;also issued 3,000,000 warrants to the note holder exercisable at $0.25/share expiring on October 31, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The warrants include price adjustment&#13;provisions whereby the exercise price will be adjusted downwards based on future grants, which results in a share issuance at a&#13;per share amount less than $0.25 per share, or repricing of any existing warrants to a lower price. During the three months ended&#13;March 31, 2013, the investor converted 1,898,588 share warrants into shares at a price of $0.0572 per share (Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option and equity based on the calculated fair value. The fair value of the conversion option was recorded at&#13;$248,000 and recognized as a derivative liability and the equity was recorded at $62,000. The fair value of the conversion option&#13;was calculated using the Binomial option pricing model under the following assumptions: estimated life of one year, risk free rate&#13;of 0.19%, dividend yield of 0% and volatility of 139.16%. The debt discount is being accreted over the one year term of the October&#13;2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $83,836 was recorded for the October 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;October 9, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On October 9, 2012, the Company converted&#13;accounts payable of $100,000 into convertible notes (the &amp;#147;October 9, 2012 Note&amp;#148;). The note holder has the option to&#13;convert a portion or all of the outstanding balance of the October 9, 2012 Note into shares of the Company&amp;#146;s common stock&#13;at a conversion rate of $0.09 per share. The note has no terms of repayment and no interest charges. Only under certain events&#13;of default the note will incur an interest rate of 20% per year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;November 1, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;During the year, the Company converted&#13;a promissory note of $100,000 (Note 7) with an accredited investor into three convertible notes of $105,000 cumulatively. The three&#13;convertible notes were assigned to a third party, of which, two notes were converted into equity. In November and December 2012,&#13;the Note holder converted $73,737 of principal and interest into 1,262,727 shares. The fair value of the shares was determined&#13;to be $140,538 based on the quoted market prices. The Company recorded $66,801 as loss on settlement of debt (Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The third Convertible Note (the &amp;#147;November&#13;1, 2012 Note&amp;#148;) was issued with a maturity date of six months in the aggregate principal amount of $31,471. The note holder&#13;has the option to convert a portion or all of the outstanding balance of the November 1, 2012 Note including any accrued interest&#13;into shares of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 65% of the lowest bid price in the 20&#13;trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The November 1, 2012 Note bears interest&#13;at the rate of 10% per annum starting on November 15, 2012. If the Company is in default under certain events, the November 1,&#13;2012 Note shall incur interest at the rate of 20% per annum retroactively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated $31,471 of the&#13;balance of the November 1, 2012 Note to the conversion option and debt based on the calculated fair value. The fair value of the&#13;conversion option was recorded at $27,300 and recognized as a derivative liability and the debt was recorded at $4,171. The fair&#13;value of the conversion option was calculated using the Binomial option pricing model under the following assumptions: estimated&#13;life of 0.49 year, risk free rate of 0.09%, dividend yield of 0% and volatility of 127.26%. The debt discount is being accreted&#13;over the 0.49 year term of the November 1, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the three months ended March 31,&#13;2013, the investor converted $15,000 and accrued interest of the November 1, 2012 Note into common shares (Note 9). The balance&#13;remaining on the November 1, 2012 Note as on March 31, 2013 was $16,471.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;For the three months ended March 31,&#13;2013, accretion of the debt discount of $7,144 was recorded for the November 1, 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;November 20, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On November 20, 2012, the Company entered&#13;into a securities purchase agreement with an accredited investor to place a Convertible Note (the &amp;#147;November 20, 2012 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $55,710. Consideration under the&#13;notes consisted of $50,000 in cash proceeds after $4,000 payment of finder&amp;#146;s fee and an original issue discount of $5,710.&#13;The note holder has the option to convert a portion or all of the outstanding balance of the November 20, 2012 Note including any&#13;accrued interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 70% of the lowest traded&#13;price in the 25 trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The August 8, 2012 Note carries no interest&#13;if the Company repays the note within 90 days from issuance. If the Company does not repay the note within 90 days, a one-time&#13;interest of 5% shall apply to the principal sum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The finder&amp;#146;s fee of $4,000 was&#13;accounted for as deferred financing costs, and is being amortized over the term of the note. At March 31, 2013, 2,564 of the $26,867&#13;in deferred financing costs relates to the November 20, 2012 Note which remains unamortized, and is presented in current assets&#13;on the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $69,000 and&#13;recognized as a derivative liability and the debt was recorded at $nil. The transaction resulted in an accounting loss on debt&#13;financing of $19,000. The fair value of the conversion option was calculated using the Binomial option pricing model under the&#13;following assumptions: estimated life of one year, risk free rate of 0.16%, dividend yield of 0% and volatility of 134.71%. The&#13;debt discount is being accreted over the one year term of the November 20, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $13,889 was recorded for the November 20, 2012 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;December 14, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On December 14, 2012, the Company converted&#13;part of the February 2011 Notes in the amount of $220,255 into a Convertible Note (the &amp;#147;December 14, 2012 Note&amp;#148;) with&#13;a maturity date of four months after the issuance thereof in the aggregate principal amount of $252,280. Consideration under the&#13;notes consisted of $220,255 from February 2011 Notes, $10,000 payment of legal fee and an original issue discount of $22,025. The&#13;December 14, 2012 Note is repayable in four equal installments with accrued interest, starting on January 18, 2013 and subsequently,&#13;the same day on each of the following calendar months. The Company can elect to pay the installments in cash or shares of Company&amp;#146;s&#13;common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The December 14, 2012 Note bears interest&#13;at the rate of 8% per annum. In the event of default under certain conditions, the interest will accrue at the rate of 18% per&#13;annum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The note holder has the option to convert&#13;a portion or all of the outstanding balance of the December 14, 2012 Note including any accrued interest into shares of the Company&amp;#146;s&#13;common stock at a conversion rate of 70% of the three lowest closing bid prices in the 20 trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In December 2012, the December 14, 2012&#13;Note was assigned to a third party and the Company paid the first installment of $65,032 consisting of principal and interest in&#13;1,078,477 shares. The fair value of the shares was determined to be $96,523 based on the quoted market price of $0.09 per share.&#13;The Company recorded $31,491 as loss on settlement of debt (Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated $189,210 of the&#13;balance of the December 14, 2012 Note to the conversion option and debt based on the calculated fair value. The fair value of the&#13;conversion option was recorded at $94,100 and recognized as a derivative liability and the debt was recorded at $95,110. The fair&#13;value of the conversion option was calculated using the Binomial option pricing model under the following assumptions: estimated&#13;life of 0.35 year, risk free rate of 0.06%, dividend yield of 0% and volatility of 100.88%. The debt discount is being accreted&#13;over the 0.45 year term of the December 14, 2012 Note using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the three months ended March 31,&#13;2013, the investor converted the remaining balance of the note of $189,210 and accrued interest on the December 14, 2012 Note into&#13;common shares (Note 9).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;December 18, 2012 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On December 18, 2012, the Company entered&#13;into a securities purchase agreement with accredited investors to place convertible notes (the &amp;#147;December 18, 2012 Notes&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $50,000. The note holders have&#13;the option to convert a portion or all of the outstanding balance of the November 20, 2012 Note including any accrued interest&#13;into shares of the Company&amp;#146;s common stock at a conversion rate of $0.10 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The December 18, 2012 Notes carry an&#13;interest rate of 9%, due and payable on the maturity date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;January 5, 2013 Convertible Notes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On January 5, 2013, the Company exchanged&#13;amounts due to related parties into convertible notes (the &amp;#147;January 5, 2013 Notes&amp;#148;) with no terms of repayment and&#13;no interest charges in the aggregate principal amount of $567,729. The related parties have the option to convert a portion or&#13;all of the outstanding balance of the January 5, 2013 Notes into shares of the Company&amp;#146;s common stock at a conversion rate&#13;of $0.08 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;b&gt;February 27, 2013 Convertible Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On February 27, 2013, the Company entered&#13;into a securities purchase agreement with an accredited investor to place a Convertible Note (the &amp;#147;February 27, 2013 Note&amp;#148;)&#13;with a maturity date of one year after the issuance thereof in the aggregate principal amount of $55,710. Consideration under the&#13;notes consisted of $46,000 in cash proceeds after $4,000 payment of finders&amp;#146; fee and an original issue discount of $5,710.&#13;The note holder has the option to convert a portion or all of the outstanding balance of the February 27, 2013 Note including any&#13;accrued interest into shares of the Company&amp;#146;s common stock at a conversion rate of $0.09 per share or 70% of the lowest traded&#13;price in the 25 trading days prior to conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The February 27, 2013 Note carries no&#13;interest if the Company repays the note within 90 days from issuance. If the Company does not repay the note within 90 days, a&#13;one-time interest of 5% shall apply to the principal sum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;The finder&amp;#146;s fee of $4,000 was&#13;accounted for as deferred financing costs, and is being amortized over the term of the note. At March 31, 2013, $3,649 of the $26,867&#13;in deferred financing costs relates to the February 27, 2013 Note which remains unamortized, and is presented in current assets&#13;on the Company&amp;#146;s Balance Sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;The Company has allocated the net proceeds&#13;to the conversion option based on the calculated fair value. The fair value of the conversion option was recorded at $44,700 and&#13;recognized as a derivative liability and the debt was recorded at $5,300. The fair value of the conversion option was calculated&#13;using the Binomial option pricing model under the following assumptions: estimated life of one year, risk free rate of 0.17%, dividend&#13;yield of 0% and volatility of 123.76%. The debt discount is being accreted over the one year term of the February 27, 2013 Note&#13;using the effective interest rate method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;For the three months ended March 31, 2013,&#13;accretion of the debt discount of $4,420 was recorded for the February 27, 2013 Note.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock>
    <us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Face Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Principal Repayment/&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Settlement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Unamortized&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Note&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Discount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Balance at&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;February 2011 Secured Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due February 24, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 1,184,694&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 203,836&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160; 120,496&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 860,362&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;April 2011 Secured Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due April 4, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;215,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;34,681&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;180,319&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;June 2011 Secured Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Senior Secured Notes, due June 6, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;30,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,271&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;26,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 8, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due August 8, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;111,430&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;65,970&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,193&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;29,267&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 12, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note became due November 12, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;August 20, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due August 20, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;20,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;7,780&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;12,220&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;September 18, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due October 1, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;82,500&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;61,750&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;10,072&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;10,678&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;October 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due October 15, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;340,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;184,438&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;155,562&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;&lt;b&gt;October 9, 2012 Convertible Notes&lt;/b&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;100,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;100,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;November 1, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due April 30, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;31,471&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;15,000&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2,381&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;14,090&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;November 20, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due November 20, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;55,710&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;35,715&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,995&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;December 14, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due April 18, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;189,210&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;189,210&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;December 18, 2012 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due December 14, 2013&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;50,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;50,000&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;January 5, 2013 Convertible Notes&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;567,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;567,729&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;February 27, 2013 Convertible Note&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Note due February 27, 2014&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;55,710&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; -&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;45,990&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;9,720&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Total&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 3,060,954&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 535,766&amp;#160;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160;&amp;#160;&amp;#160; 461,017&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;$ 2,064,171&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock>
    <tpiv:AggregatePrincipalAmount contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">1184694</tpiv:AggregatePrincipalAmount>
    <tpiv:AggregatePrincipalAmount contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">6250</tpiv:AggregatePrincipalAmount>
    <tpiv:CashProceeds contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">944694</tpiv:CashProceeds>
    <tpiv:OutstandingAndDemandable contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">240000</tpiv:OutstandingAndDemandable>
    <tpiv:PerShare contextRef="AsOf2011-02-24" unitRef="USDPShares" decimals="INF">0.15</tpiv:PerShare>
    <tpiv:PerShare1 contextRef="AsOf2011-02-24" unitRef="USDPShares" decimals="INF">0.15</tpiv:PerShare1>
    <tpiv:PaidFee contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">41500</tpiv:PaidFee>
    <tpiv:DeferredFinancingCosts contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">11597</tpiv:DeferredFinancingCosts>
    <tpiv:DeferredFinancingCosts1 contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts1>
    <tpiv:IssuedWarrants contextRef="AsOf2011-02-24" unitRef="Shares" decimals="INF">2369388</tpiv:IssuedWarrants>
    <tpiv:CommonStock contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">0.25</tpiv:CommonStock>
    <tpiv:CommonStockSold contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">25000</tpiv:CommonStockSold>
    <tpiv:FairValueOfWarrants contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">483355</tpiv:FairValueOfWarrants>
    <tpiv:DerivativeLiabilitiesAndDebt contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">701339</tpiv:DerivativeLiabilitiesAndDebt>
    <tpiv:PrincipalAmount contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">203836</tpiv:PrincipalAmount>
    <tpiv:AccruedInterest contextRef="AsOf2011-02-24" unitRef="USD" decimals="0">16419</tpiv:AccruedInterest>
    <tpiv:AccretionOfDebtDiscount contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">32862</tpiv:AccretionOfDebtDiscount>
    <tpiv:PrincipalAmount1 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">215000</tpiv:PrincipalAmount1>
    <tpiv:CashProceeds1 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">190000</tpiv:CashProceeds1>
    <tpiv:SubscribedCash contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">25000</tpiv:SubscribedCash>
    <tpiv:PerShare2 contextRef="AsOf2011-04-04" unitRef="USDPShares" decimals="INF">0.15</tpiv:PerShare2>
    <tpiv:PerShare4 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">0.15</tpiv:PerShare4>
    <tpiv:PaidFee2 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">4550</tpiv:PaidFee2>
    <tpiv:DeferredFinancingCosts2 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">1517</tpiv:DeferredFinancingCosts2>
    <tpiv:DeferredFinancingCosts3 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts3>
    <tpiv:IssuedWarrants1 contextRef="AsOf2011-04-04" unitRef="Shares" decimals="INF">430000</tpiv:IssuedWarrants1>
    <tpiv:CommonStockSold1 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">25000</tpiv:CommonStockSold1>
    <tpiv:FairValueOfWarrants1 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">130720</tpiv:FairValueOfWarrants1>
    <tpiv:DerivativeLiabilitiesAndDebt1 contextRef="AsOf2011-04-04" unitRef="USD" decimals="0">84280</tpiv:DerivativeLiabilitiesAndDebt1>
    <tpiv:AccretionOfDebtDiscount1 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">8459</tpiv:AccretionOfDebtDiscount1>
    <tpiv:PrincipalAmount2 contextRef="AsOf2011-06-06" unitRef="USD" decimals="0">30000</tpiv:PrincipalAmount2>
    <tpiv:PrincipalAmount2 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">111430</tpiv:PrincipalAmount2>
    <tpiv:PerShare5 contextRef="AsOf2011-06-06" unitRef="USDPShares" decimals="INF">0.15</tpiv:PerShare5>
    <tpiv:PerShare3 contextRef="AsOf2011-06-06" unitRef="USDPShares" decimals="INF">0.15</tpiv:PerShare3>
    <tpiv:PerShare3 contextRef="AsOf2012-07-08" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare3>
    <tpiv:IssuedWarrants2 contextRef="AsOf2011-06-06" unitRef="Shares" decimals="INF">60000</tpiv:IssuedWarrants2>
    <tpiv:CommonStock1 contextRef="AsOf2011-06-06" unitRef="USD" decimals="0">0.25</tpiv:CommonStock1>
    <tpiv:FairValueOfWarrants2 contextRef="AsOf2011-06-06" unitRef="USD" decimals="0">8280</tpiv:FairValueOfWarrants2>
    <tpiv:DerivativeLiabilitiesAndDebt2 contextRef="AsOf2011-06-06" unitRef="USD" decimals="0">21720</tpiv:DerivativeLiabilitiesAndDebt2>
    <tpiv:AccretionOfDebtDiscount2 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">682</tpiv:AccretionOfDebtDiscount2>
    <tpiv:CashProceeds2 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">92000</tpiv:CashProceeds2>
    <tpiv:PaymentFee contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">8000</tpiv:PaymentFee>
    <tpiv:DiscountIssue contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">11430</tpiv:DiscountIssue>
    <tpiv:DeferredFinancingCosts4 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">8000</tpiv:DeferredFinancingCosts4>
    <tpiv:DeferredFinancingCosts5 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">1360</tpiv:DeferredFinancingCosts5>
    <tpiv:DeferredFinancingCosts6 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts6>
    <tpiv:FairValueOfConversion contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">155700</tpiv:FairValueOfConversion>
    <tpiv:AccountingLossOnDebtFinancing contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">55700</tpiv:AccountingLossOnDebtFinancing>
    <tpiv:AccretionOfDebtDiscount3 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">11209</tpiv:AccretionOfDebtDiscount3>
    <tpiv:PrincipalAmount4 contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">27500</tpiv:PrincipalAmount4>
    <tpiv:CashProceeds3 contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">25000</tpiv:CashProceeds3>
    <tpiv:DiscountIssue1 contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">2500</tpiv:DiscountIssue1>
    <tpiv:ShareIssued contextRef="AsOf2012-07-12" unitRef="Shares" decimals="INF">50000</tpiv:ShareIssued>
    <tpiv:ValuedShares contextRef="AsOf2012-07-12" unitRef="Shares" decimals="INF">50000</tpiv:ValuedShares>
    <tpiv:FairValueOfConversion1 contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">31100</tpiv:FairValueOfConversion1>
    <tpiv:AccountingLossOnDebtFinancing1 contextRef="AsOf2012-07-12" unitRef="USD" decimals="0">6100</tpiv:AccountingLossOnDebtFinancing1>
    <tpiv:PrincipalAmount5 contextRef="AsOf2012-07-20" unitRef="USD" decimals="0">20000</tpiv:PrincipalAmount5>
    <tpiv:PerShare6 contextRef="AsOf2012-07-20" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare6>
    <tpiv:FairValueOfConversion2 contextRef="AsOf2012-07-20" unitRef="USD" decimals="0">36100</tpiv:FairValueOfConversion2>
    <tpiv:AccountingLossOnDebtFinancing2 contextRef="AsOf2012-07-20" unitRef="USD" decimals="0">16100</tpiv:AccountingLossOnDebtFinancing2>
    <tpiv:AccretionOfDebtDiscount4 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">4932</tpiv:AccretionOfDebtDiscount4>
    <tpiv:PrincipalAmount6 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">82500</tpiv:PrincipalAmount6>
    <tpiv:CashProceeds4 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">69000</tpiv:CashProceeds4>
    <tpiv:DiscountIssue3 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">7500</tpiv:DiscountIssue3>
    <tpiv:PerShare7 contextRef="AsOf2012-08-18" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare7>
    <tpiv:DeferredFinancingCosts7 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">6000</tpiv:DeferredFinancingCosts7>
    <tpiv:DeferredFinancingCosts8 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">755</tpiv:DeferredFinancingCosts8>
    <tpiv:DeferredFinancingCosts9 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts9>
    <tpiv:FairValueOfConversion3 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">76400</tpiv:FairValueOfConversion3>
    <tpiv:AccountingLossOnDebtFinancing3 contextRef="AsOf2012-08-18" unitRef="USD" decimals="0">1400</tpiv:AccountingLossOnDebtFinancing3>
    <tpiv:AccruedInterest2 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">61750</tpiv:AccruedInterest2>
    <tpiv:AccretionOfDebtDiscount5 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">4954</tpiv:AccretionOfDebtDiscount5>
    <tpiv:PrincipalAmount7 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">340000</tpiv:PrincipalAmount7>
    <tpiv:CashProceeds5 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">310000</tpiv:CashProceeds5>
    <tpiv:LegalFee contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">10000</tpiv:LegalFee>
    <tpiv:DiscountIssue2 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">30000</tpiv:DiscountIssue2>
    <tpiv:DeferredFinancingCosts10 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">10000</tpiv:DeferredFinancingCosts10>
    <tpiv:DeferredFinancingCosts11 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">5425</tpiv:DeferredFinancingCosts11>
    <tpiv:DeferredFinancingCosts12 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts12>
    <tpiv:CommonStockShares contextRef="AsOf2012-10-15" unitRef="Shares" decimals="INF">2833333</tpiv:CommonStockShares>
    <tpiv:IssuedWarrants3 contextRef="AsOf2012-10-15" unitRef="Shares" decimals="INF">3000000</tpiv:IssuedWarrants3>
    <tpiv:PerShare8 contextRef="AsOf2012-10-15" unitRef="USDPShares" decimals="INF">0.0572</tpiv:PerShare8>
    <tpiv:FairValueOfConversion4 contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">248000</tpiv:FairValueOfConversion4>
    <tpiv:DerivativeLiabilitiesAndEquity contextRef="AsOf2012-10-15" unitRef="USD" decimals="0">62000</tpiv:DerivativeLiabilitiesAndEquity>
    <tpiv:AccretionOfDebtDiscount6 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">83836</tpiv:AccretionOfDebtDiscount6>
    <tpiv:AccountsPayble contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">100000</tpiv:AccountsPayble>
    <tpiv:PerShare9 contextRef="AsOf2012-10-09" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare9>
    <tpiv:PromissoryNotes contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">100000</tpiv:PromissoryNotes>
    <tpiv:ConvertibleNotes contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">105000</tpiv:ConvertibleNotes>
    <tpiv:PrincipalAmountAndIntrest contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">73737</tpiv:PrincipalAmountAndIntrest>
    <tpiv:Shares contextRef="AsOf2012-10-09" unitRef="Shares" decimals="INF">1262727</tpiv:Shares>
    <tpiv:SharesDetermined contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">140538</tpiv:SharesDetermined>
    <tpiv:Recorded contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">66801</tpiv:Recorded>
    <tpiv:PrincipalAmount8 contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">31471</tpiv:PrincipalAmount8>
    <tpiv:PerShare10 contextRef="AsOf2012-10-09" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare10>
    <tpiv:AllocatedBalance contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">31471</tpiv:AllocatedBalance>
    <tpiv:Recorded1 contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">27300</tpiv:Recorded1>
    <tpiv:DerivativeLiabilitiesAndDebt3 contextRef="AsOf2012-10-09" unitRef="USD" decimals="0">4171</tpiv:DerivativeLiabilitiesAndDebt3>
    <tpiv:AccruedInterest3 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">15000</tpiv:AccruedInterest3>
    <tpiv:RemainingBalance contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">16471</tpiv:RemainingBalance>
    <tpiv:AccretionOfDebtDiscount7 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">7144</tpiv:AccretionOfDebtDiscount7>
    <tpiv:PrincipalAmount9 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">55710</tpiv:PrincipalAmount9>
    <tpiv:NotesConsisted contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">50000</tpiv:NotesConsisted>
    <tpiv:CashProceeds6 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">4000</tpiv:CashProceeds6>
    <tpiv:DiscountIssued contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">5710</tpiv:DiscountIssued>
    <tpiv:PerShare11 contextRef="AsOf2012-11-20" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare11>
    <tpiv:DeferredFinancingCosts13 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">4000</tpiv:DeferredFinancingCosts13>
    <tpiv:DeferredFinancingCosts14 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts14>
    <tpiv:FairValueOfConversion5 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">69000</tpiv:FairValueOfConversion5>
    <tpiv:AccountingLossOnDebtFinancing4 contextRef="AsOf2012-11-20" unitRef="USD" decimals="0">19000</tpiv:AccountingLossOnDebtFinancing4>
    <tpiv:AccretionOfDebtDiscount8 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">13889</tpiv:AccretionOfDebtDiscount8>
    <tpiv:ConvertableNoteAmount contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">220255</tpiv:ConvertableNoteAmount>
    <tpiv:PrincipalAmount10 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">252280</tpiv:PrincipalAmount10>
    <tpiv:NotesConsisted2 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">220255</tpiv:NotesConsisted2>
    <tpiv:LegalFee3 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">10000</tpiv:LegalFee3>
    <tpiv:DiscountIssue4 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">22025</tpiv:DiscountIssue4>
    <tpiv:PrincipalAmountAndIntrest1 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">1078477</tpiv:PrincipalAmountAndIntrest1>
    <tpiv:FairValueOfShares contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">96523</tpiv:FairValueOfShares>
    <tpiv:PerShare12 contextRef="AsOf2012-12-14" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare12>
    <tpiv:RecordedLoss contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">31491</tpiv:RecordedLoss>
    <tpiv:AllocatedBalance1 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">189210</tpiv:AllocatedBalance1>
    <tpiv:FairValueOfConversion7 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">94100</tpiv:FairValueOfConversion7>
    <tpiv:DerivativeLiabilitiesAndDebt5 contextRef="AsOf2012-12-14" unitRef="USD" decimals="0">95110</tpiv:DerivativeLiabilitiesAndDebt5>
    <tpiv:RemainingBalance1 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">189210</tpiv:RemainingBalance1>
    <tpiv:PrincipalAmount14 contextRef="AsOf2012-12-18" unitRef="USD" decimals="0">50000</tpiv:PrincipalAmount14>
    <tpiv:PerShare13 contextRef="AsOf2012-12-18" unitRef="USDPShares" decimals="INF">0.10</tpiv:PerShare13>
    <tpiv:PrincipalAmount15 contextRef="AsOf2013-01-05" unitRef="USD" decimals="0">567729</tpiv:PrincipalAmount15>
    <tpiv:PerShare14 contextRef="AsOf2013-01-05" unitRef="USDPShares" decimals="INF">0.08</tpiv:PerShare14>
    <tpiv:PrincipalAmount16 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">55710</tpiv:PrincipalAmount16>
    <tpiv:NotesConsisted3 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">46000</tpiv:NotesConsisted3>
    <tpiv:CashProceeds7 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">4000</tpiv:CashProceeds7>
    <tpiv:DiscountIssue5 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">5710</tpiv:DiscountIssue5>
    <tpiv:PerShare15 contextRef="AsOf2013-02-27" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare15>
    <tpiv:DeferredFinancingCosts16 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">4000</tpiv:DeferredFinancingCosts16>
    <tpiv:DeferredFinancingCosts17 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">3649</tpiv:DeferredFinancingCosts17>
    <tpiv:DeferredFinancingCosts18 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">26867</tpiv:DeferredFinancingCosts18>
    <tpiv:FairValueOfConversion8 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">44700</tpiv:FairValueOfConversion8>
    <tpiv:DerivativeLiabilitiesAndDebt8 contextRef="AsOf2013-02-27" unitRef="USD" decimals="0">5300</tpiv:DerivativeLiabilitiesAndDebt8>
    <tpiv:AccretionOfDebtDiscount9 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">4420</tpiv:AccretionOfDebtDiscount9>
    <tpiv:AccruedInterest1 contextRef="AsOf2012-07-08" unitRef="USD" decimals="0">65970</tpiv:AccruedInterest1>
    <us-gaap:ScheduleOfDueToFromBrokerDealersAndClearingOrganizationsTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 6:&amp;#9;Loans&#13;payable&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;As at March 31, 2013, there were unsecured&#13;loan advances from third parties in the amount of $10,000 (December 31, 2012 - $10,000), which is due on demand. The loan is accruing&#13;interest of 10% per annum.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfDueToFromBrokerDealersAndClearingOrganizationsTextBlock>
    <tpiv:UnsecuredLoan contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">10000</tpiv:UnsecuredLoan>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 7:&amp;#9;Promissory&#13;note&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the year ended December 31, 2011,&#13;the Company issued a note in the amount of $100,000 towards future legal services, which matured July 24, 2011. As of December&#13;31, 2012, the Company had received legal services in the amount of $100,000 against the note. The note bears interest at 10% per&#13;annum and may be converted into shares at equal to lower of $0.09 or 65% of the arithmetic average of the lowest closing bid prices&#13;of the Company&amp;#146;s shares during the consecutive twenty day trading period prior to notice of conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the year ended December 31, 2012,&#13;the Company issued 500,000 shares to the holder of the note in exchange for the note holder&amp;#146;s agreement to forbear from pursuing&#13;collections actions on the outstanding note (Note 9) and converted the promissory note into three convertible notes (Note 5).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the year ended December 31, 2012,&#13;the Company issued additional promissory notes in the amount of $67,942, of which $38,000 of promissory notes were issued to an&#13;officer and a director of the Company (Note 8). These promissory notes were fully outstanding as at March 31, 2013 and had no interest&#13;charges and no fixed repayment terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the year ended December 31, 2012,&#13;the Company converted accounts payable into a promissory note in the amount of $100,000. The note incurs interest at 8% per year&#13;and can be converted into shares at the option of the note holder at a conversion price of $0.09 per share. If the Company defaults&#13;under certain conditions, the note shall incur interest at 20% per year. These promissory notes were fully outstanding as at March&#13;31, 2013 and had no fixed repayment terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;During the three months ended March 31,&#13;2013, the Company converted $210,000 of accounts payable into a promissory note, payable on a preset schedule of payments starting&#13;in April 2013. Any of the late payments will incur interest at the rate of 9%.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <tpiv:AmountIssued contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">100000</tpiv:AmountIssued>
    <tpiv:LegalServices contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">100000</tpiv:LegalServices>
    <tpiv:ShareIssued1 contextRef="From2012-01-01to2012-12-31" unitRef="Shares" decimals="INF">500000</tpiv:ShareIssued1>
    <tpiv:IssuedAditionalPromissoryNotes contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">67942</tpiv:IssuedAditionalPromissoryNotes>
    <tpiv:IssuedPromissoryNotesToOfficer contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">38000</tpiv:IssuedPromissoryNotesToOfficer>
    <tpiv:AccountsPaybleIntoPromissoryNotes contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">100000</tpiv:AccountsPaybleIntoPromissoryNotes>
    <tpiv:PerShare16 contextRef="From2012-01-01to2012-12-31" unitRef="USDPShares" decimals="INF">0.09</tpiv:PerShare16>
    <tpiv:AccountsPaybleIntoPromissoryNotes1 contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">210000</tpiv:AccountsPaybleIntoPromissoryNotes1>
    <tpiv:NetLoss contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">-441432</tpiv:NetLoss>
    <tpiv:NetLoss contextRef="From2012-01-01to2012-03-31" unitRef="USD" decimals="0">-598572</tpiv:NetLoss>
    <tpiv:NetLoss contextRef="From1999-07-27to2013-03-31" unitRef="USD" decimals="0">-50335515</tpiv:NetLoss>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 8:&amp;#9;Related&#13;Party Transactions&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;During&#13;the &lt;/font&gt;three months ended March 31, 2013&lt;font style="letter-spacing: -0.1pt"&gt;, the Company entered into transactions with certain&#13;officers and directors of the Company as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(a)&lt;font style="font: 7pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&lt;/font&gt;incurred $88,500 (March 31, 2012 - $80,100) in management, consulting and directors &amp;#145;fees and $33,000 (March 31, 2011&#13;- $22,500) in research and development services paid or accrued to officers and directors during the period;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(b)&lt;font style="font: 7pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&lt;/font&gt;recorded $25,643 (March 31, 2012 - $29,562) in stock based compensation for the fair value of options granted to management&#13;and consultants that were granted and or vested during the period;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(c)&lt;font style="font: 7pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&lt;/font&gt;converted $nil (March 31, 2012 - $50,000) of debt due to related parties during the period, which were settled with shares.&#13;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;(d)&lt;font style="font: 7pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&lt;/font&gt;converted $567,729 (2012 - $nil) of payable into convertible notes to officers, consultant and a director of the Company&#13;(Note 5).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;All related party transactions&#13;(other than stock based consideration) involving provision of services were recorded at the &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;exchange&#13;amount, which is the amount established and agreed to by the related parties as representing fair value. The Company accounted&#13;for the debt settlement transactions with related parties at management&amp;#146;s estimate of fair value, using amounts similar to&#13;arm&amp;#146;s length settlements for debt settled.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0"&gt;At March 31, 2013, the Company had amounts owing to directors, consultants and officers of $762,574 (December&#13;31, 2012 - $373,345). Amounts due to related parties are unsecured, non-interest bearing and have no specific terms of repayment.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <tpiv:ManagementConsultingAndDirectorsFees contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">88500</tpiv:ManagementConsultingAndDirectorsFees>
    <tpiv:ManagementConsultingAndDirectorsFees1 contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">80100</tpiv:ManagementConsultingAndDirectorsFees1>
    <tpiv:ResearchAndDevelopmentServicesPaid contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">33000</tpiv:ResearchAndDevelopmentServicesPaid>
    <tpiv:ResearchAndDevelopmentServicesPaid1 contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">22500</tpiv:ResearchAndDevelopmentServicesPaid1>
    <tpiv:StockBasedCompensation contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">25643</tpiv:StockBasedCompensation>
    <tpiv:StockBasedCompensation1 contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">29562</tpiv:StockBasedCompensation1>
    <tpiv:DebtDueToRelatedParties contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">50000</tpiv:DebtDueToRelatedParties>
    <tpiv:PayableIntoConvertibleNotes contextRef="From2013-01-01to2013-03-31" unitRef="USD" decimals="0">567729</tpiv:PayableIntoConvertibleNotes>
    <tpiv:OwingToDirectorsConsultantsAndOfficers contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">762574</tpiv:OwingToDirectorsConsultantsAndOfficers>
    <tpiv:OwingToDirectorsConsultantsAndOfficers1 contextRef="AsOf2013-03-31" unitRef="USD" decimals="0">373345</tpiv:OwingToDirectorsConsultantsAndOfficers1>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 10:&amp;#9;Supplemental&#13;Cash Flow Information AND NON-CASH INVESTING AND FINANCING ACTIVITIES &lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;Three Months Ended&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;March 31, 2013&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Shares/warrants&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Amount&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; $&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to consulting arrangements&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;350,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;38,935&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to notes conversion&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;5,476,848&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;348,845&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Three Months Ended&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;March 31, 2012&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Shares/warrants&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Amount&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; $&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to debt settlement agreements&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,363,112&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160; $211,187&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 50%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;See Notes 5 and 9 for additional disclosure&#13;on non-cash transactions.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td rowspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Period Ended March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest paid in cash&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 12.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 15.9pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Income taxes paid&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 12.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 15.9pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;Three Months Ended&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;March 31, 2013&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Shares/warrants&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Amount&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; $&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to consulting arrangements&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;350,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;38,935&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to notes conversion&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;5,476,848&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;348,845&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="vertical-align: top; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Three Months Ended&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;March 31, 2012&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="vertical-align: bottom; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Shares/warrants&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Amount&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; $&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shares issued pursuant to debt settlement agreements&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,363,112&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160; $211,187&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 50%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td rowspan="2" style="border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-top: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Period Ended March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest paid in cash&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 12.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 15.9pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Income taxes paid&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 12.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1.5pt solid; padding-right: 15.9pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; -&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 11:&amp;#9;ContingencIES&#13;AND COMMITMENTs&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Contingencies&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Tax Filings&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;The&#13;Company has not filed income tax returns for several years in certain operating jurisdictions (Note 10), and may be subject to&#13;possible compliance penalties and interest. Management is currently not able to make a reliably measurable provision for possible&#13;liability for penalties and interest, if any, at this time, and the Company may be liable for such amounts upon assessment. Penalties&#13;and interest, if assessed in the future, will be recorded in the period such amounts are determinable.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Commitments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Combined Research and&#13;Operating Obligations&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;Effective&#13;May 25, 2010, the Company entered into a research and license Option Agreement with the Mayo Clinic for the development and possible&#13;commercial use of a cancer vaccine. Subject to the approval and guidance of the United States Food and Drug Administration (&amp;#147;FDA&amp;#148;)&#13;the Mayo Clinic plans to conduct a Phase I human clinical trial (&amp;#147;Phase I Trial&amp;#148;) to test and develop the Company&amp;#146;s&#13;technology. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;The&#13;Company has agreed that, during the period of the option and upon approval of FDA to conduct Phase I Trials, will pay all the costs&#13;incurred by the Mayo Clinic, not to exceed a total of $841,000, of which, $618,823 has been accrued as of March 31, 2013. Both&#13;Parties agree that within 30 days after the Mayo Clinic informs the Company in writing about the receipt of FDA approval, the parties&#13;shall enter into an a formal research agreement. Management anticipates that Phase 1 Trials will begin in the second quarter of&#13;2013. An initial payment of $250,000 will be required within 30 days of receiving notice from the Mayo&lt;/font&gt; Clinic that the Phase&#13;1 Trial will commence.&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Management Services Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In February&#13;2011, the Company approved an employment agreement with Dr. Wilson with an initial term of 2 years, which may be automatically&#13;extended for successive one-year terms. This employment agreement provides for annual compensation of $180,000 and the grant of&#13;an option to acquire 2,000,000 shares of the Company&amp;#146;s common stock at $0.19 per share, 50% of which vested on March 16,&#13;2011, while the remainder will vest monthly over a period of two years (41,667 per month). The options shall be exercisable for&#13;at least five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Consultant Agreements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In April&#13;2012, the Company entered into an investors&amp;#146; relation consulting agreement for a one year term, with a one-time right to&#13;terminate the agreement at its six month anniversary. The consulting agreement provides for the Company to issue 620,690 shares&#13;to the consultant and a monthly payment of $7,500.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In April&#13;2012, the Company entered into financial consulting service agreements, which included compensation of 14,000,000 shares of common&#13;stock, whereby the Company agreed to issue additional shares to the consultants to restore their holdings to 24.8% of fully diluted&#13;capitalization of the Company if the Company completes a re-organization, re-capitalization or a liquidity event during the eighteen&#13;months commencing with the signing of these agreements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In May&#13;2012, the Company entered into a one year consulting services agreement superseding the previous management consulting agreement&#13;with Mr. Corin to provide expertise in the areas of finance and corporate development to the Management and Board of TapImmune.&#13;The consulting services agreement provides for a consulting fee of $12,000 per month from May 2012 to December 2012 and $10,000&#13;for the following four months. The Company also granted 250,000 options to Mr. Corin, vesting equally over twelve months at an&#13;exercise price of $0.17 with a ten year term.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Rental Lease Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In December&#13;2011, the Company entered into a lease agreement, to start in January 2012 for a two year period. The Company will pay a monthly&#13;basic rent of $7,152 and additional rent for operating costs of 2.20% of total operating expenses of the property.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;The Company&#13;has obligations under various research and consulting agreements through December 31, 2014. The aggregate minimum annual payments&#13;for the years ending December 31 are as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"&gt;2013&amp;#9;$&amp;#9;638,316&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"&gt;2014&amp;#9;&lt;u&gt;&amp;#9;22,284&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"&gt;&amp;#9;&lt;u&gt;$&amp;#9;660,599&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Refer to Note 13 Subsequent Events.&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;&amp;#160;&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 12:&amp;#9;accounts&#13;payable and accrued liabilities&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold; margin: 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Accounts Payable and Accrued&#13;Liabilities&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;March 31, 2013&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;December 31, 2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;$&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;$&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Trade accounts payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,459,469 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,663,315 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Accrued liabilities&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;183,245 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 242,245&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Employee payroll&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;132,916 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 61,458&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Accrued interest&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;122,833 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 74,698&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,898,463 &lt;font style="font-size: 8pt; letter-spacing: 0pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;2,041,716 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;hr class="msocomoff" align="left" size="1" style="width: 33%" /&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;March 31, 2013&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;December 31, 2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;$&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;$&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Trade accounts payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,459,469 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,663,315 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Accrued liabilities&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;183,245 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 242,245&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Employee payroll&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;132,916 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 61,458&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;Accrued interest&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;122,833 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 74,698&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;1,898,463 &lt;font style="font-size: 8pt; letter-spacing: 0pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;2,041,716 &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-top: windowtext 0.5pt solid; border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 13:&amp;#9;SUBSEQUENT&#13;EVENTS&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is in default of the secured notes&#13;issued in February 2011. No second year amortization payments have been made to the holders as of the anniversary of the notes&#13;in February 2013 and April 2013. Interest charges will be accrued at 20% per year. The note holders have not made any demands other&#13;than the interest rate penalty and are in discussions with the Company to resolve the matter.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company was in default of the October 2012&#13;note to a note holder due to the late filing of its annual report. Concurrent with the filing, this default will be cured. The&#13;lender has not made any claims under their default provisions and management is working closely with them to mitigate or negate&#13;any such claims.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0"&gt;In May 2013, the Company recovered 2,800,000 of 14,000,000 common shares issued to a consultant during the&#13;year ended December 31, 2012, under a settlement agreement.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ComputationOfNetCapitalUnderSecuritiesAndExchangeCommissionRegulationTextBlock contextRef="From2013-01-01to2013-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;font style="text-transform: uppercase"&gt;&lt;u&gt;Note 9:&amp;#9;Capital&#13;Stock&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Share Capital&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;Prior&#13;to March 27, 2007, the authorized capital of the Company consisted of 50,000,000 common shares with $0.001 par value and 5,000,000&#13;non-voting preferred shares with $0.001 par value. On March 27, 2007, the Company&amp;#146;s Articles of Incorporation were amended&#13;to increase the authorized shares of common stock from 50,000,000 shares of common stock to 200,000,000 shares. On June 28, 2007,&#13;the Company completed a reverse stock split thereby issuing 1 new share for each 2.5 outstanding shares of the Company&amp;#146;s&#13;common stock. Accordingly, the Company&amp;#146;s authorized share capital was decreased from 200,000,000 common shares to 80,000,000&#13;common shares. On January 22, 2009 the authorized shares of common stock increased from 80,000,000 shares to 500,000,000 shares.&lt;/font&gt;&#13;Effective July 10, 2009, the Company executed a further 1 for 10 reverse stock split while simultaneously reducing the authorized&#13;shares of common stock to 50,000,000 common shares with a $0.001 par value. Effective February 21, 2010, the Company increased&#13;its authorized shares of common stock from 50,000,000 shares to 150,000,000 common shares. The Company maintained its authorized&#13;shares of preferred stock at 5,000,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;All prior period share transactions included&#13;in the Company&amp;#146;s stock transactions and balances have been retroactively restated for the transactions described above.&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;2013 Share Transactions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;January 2013, the Company issued &lt;/font&gt;231,332 shares of its restricted common stock for conversion of one of the two November&#13;1, 2012 Notes (Note 5) at a conversion price of $.0662 per share. The fair value of the shares was determined to be $36,550 based&#13;on the quoted market price of $0.158 per share. The Company recorded $21,230 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In February 2013, the Company issued&#13;250,000 common shares to a consultant pursuant to a consulting agreement. The fair value of the shares was determined to be $28,925&#13;based on the quoted market price of $0.116 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In February 2013, the Company issued&#13;1,898,588 common shares on a cashless conversion of 3,000,000 warrants at an exercise price of $0.0572. The fair value of the shares&#13;was determined to be $246,816 based on the quoted market price of $0.13 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In March 2013, the Company issued 100,000&#13;common shares to a consultant pursuant to a consulting agreement. The fair value of the shares was determined to be $10,010 based&#13;on the quoted market price of $0.1001 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In February and March 2013, the Company&#13;received subscription proceeds of $242,950. The subscribers purchased 3,470,709 share units at $0.07 per unit. Each unit consists&#13;of one share of Company&amp;#146;s common stock and one warrant exercisable at $0.07, which expires in two years. The fair value of&#13;these warrants was determined to be $245,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;During&#13;the period ended March 31, 2013, the Company issued &lt;/font&gt;3,176,334 shares of its restricted common stock for conversion of December&#13;14, 2012 Note (Note 5) at a conversion price of $.0603 per share. The fair value of the shares was determined to be $404,849 based&#13;on the average quoted market price of $0.1245 per share. The Company recorded $213,316 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;During&#13;the period ended March 31, 2013, the Company issued &lt;/font&gt;992,063 shares of its restricted common stock for partial conversion&#13;of September 18, 2012 Note (Note 5) at an average conversion price of $.0695 per share. The fair value of the shares was determined&#13;to be $125,179 based on the average quoted market price of $0.1228 per share. The Company recorded $55,179 as loss on settlement&#13;of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;During&#13;the period ended March 31, 2013, the Company issued &lt;/font&gt;1,050,000 shares of its restricted common stock for partial conversion&#13;of August 8, 2012 Note (Note 5) at an average conversion price of $.0681 per share. The fair value of the shares was determined&#13;to be $110,700 based on the average quoted market price of $0.1063 per share. The Company recorded $39,160 as loss on settlement&#13;of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;2012 Share Transactions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;On&#13;March 15, 2012, the Company issued 333,334 shares of its restricted common stock to related parties, pursuant to debt settlement&#13;agreements to settle $50,000 of outstanding trade payable. &lt;/font&gt;At the time of issuance the fair value of the shares was determined&#13;to be $50,000 based on the quoted market price of $0.15 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;On&#13;March 15, 2012, the Company issued &lt;/font&gt;400,000 shares of its restricted common stock pursuant to a debt settlement and a consulting&#13;agreement. At the time of issuance the fair value of the shares was determined to be $71,200 based on the quoted market price of&#13;$0.15 per share. The Company recorded $9,930 as gain on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;On&#13;March 15, 2012, the Company issued &lt;/font&gt;789,778 shares of its restricted common stock in settlement of accrued interest on the&#13;outstanding 2011 Notes. At the time of issuance the fair value of the shares was determined to be $118,467 based on the quoted&#13;market price of $0.15 per share. No gain or loss was recorded on settlement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In March 2012, the Company received subscription&#13;proceeds of $85,000. The subscribers purchased 733,334 share units at $0.15 per unit. Each unit consists of 1 share of Company&amp;#146;s&#13;common stock and half a warrant exercisable at $0.40, which expires in two years. The fair value of these warrants was determined&#13;to be $5,133.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In April 2012, the Company received subscription&#13;proceeds of $345,000. The subscribers purchased 2,300,000 share units at $0.15 per unit. Each unit consists of 1 share of Company&amp;#146;s&#13;common stock and half a warrant exercisable at $0.40, which expires in two years. The fair value of these warrants was determined&#13;to be $123,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In April, 2012, the Company&#13;issued 1&lt;/font&gt;00,000 shares of its restricted common stock pursuant to a debt settlement and a consulting agreement. At the time&#13;of issuance the fair value of the shares was determined to be $18,500 based on the quoted market price of $0.185 per share. The&#13;Company recorded $18,758 as gain on settlement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"&gt;In April 2012, the Company issued 933,333 restricted common&#13;shares, at $0.15 per share, for proceeds of $140,000 received in October 2011, in a private placement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In April 2012, the Company issued 1,000,000&#13;common shares to a consultant pursuant to a consulting agreement effective October 1, 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;April, 2012, the Company issued &lt;/font&gt;163,334 shares of its restricted common stock in settlement of accrued interest on the outstanding&#13;2011 Notes. At the time of issuance the fair value of the shares was determined to be $24,500 based on the quoted market price&#13;of $0.15 per share. No gain or loss was recorded on settlement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;In May 2012, the Company issued 14,000,000&#13;common shares to consultants pursuant to a consulting agreement (Note 12). At the time of issuance the fair value of the shares&#13;was determined to be $1,918,000 based on the quoted market price of $0.137 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;June 2012, the Company issued &lt;/font&gt;35,179 shares of its restricted common stock pursuant to a consulting agreement. The fair&#13;value of the shares was determined to be $6,000 based on the quoted market price of $0.17 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;August 2012, the Company issued &lt;/font&gt;500,000 shares of its restricted common stock pursuant to a consulting agreement. The fair&#13;value of the shares was determined to be $74,000 based on the quoted market price of $0.148 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;September 2012, the Company issued &lt;/font&gt;500,000 shares of its restricted common stock to the holder of a promissory note in exchange&#13;for the note holder&amp;#146;s agreement to forebear from pursuing collection action on that note (Note 7). The fair value of the&#13;shares was determined to be $72,750 based on the quoted market price of $0.146 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;November 2012, the Company issued &lt;/font&gt;437,063 shares of its restricted common stock on election by the holder to convert part&#13;of a convertible debt (Note 5) at a conversion price of $.0572 per share. The fair value of the shares was determined to be $55,944&#13;based on the quoted market price of $0.128 per share. The Company recorded $30,944 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;November 2012, the Company issued &lt;/font&gt;597,185 shares of its restricted common stock on election by the holder to convert part&#13;of a convertible debt (Note 5) at a conversion price of $.0586 per share. The fair value of the shares was determined to be $63,003&#13;based on the quoted market price of $0.106 per share. The Company recorded $28,003 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;November 2012, the Company issued &lt;/font&gt;228,479 shares of its restricted common stock on election by the holder to convert part&#13;of a convertible debt (Note 5) at a conversion price of $.0601 per share. The fair value of the shares was determined to be $21,591&#13;based on the quoted market price of $0.095 per share. The Company recorded $7,854 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;December 2012, the Company issued &lt;/font&gt;1,078,477 shares of its restricted common stock as payment of installment of $65,032 for&#13;a convertible debt (Note 5) at a conversion price of $.0603 per share. The fair value of the shares was determined to be $96,523&#13;based on the quoted market price of $0.09 per share. The Company recorded $31,491 as loss on settlement of debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Stock Compensation Plan&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On October 14, 2009, the Company adopted&#13;the 2009 Stock Incentive Plan (the &amp;#147;2009 Plan&amp;#148;) which supersedes and replaces the 2007 Stock Plan. The 2009 Plan allows&#13;for the issuance of up to 10,000,000 common shares. &lt;font style="letter-spacing: -0.1pt"&gt;Options granted under the Plan shall be&#13;at prices and for terms as determined by the Board of Directors.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On April 30, 2012, the Company granted&#13;250,000 stock options to a management at an exercise price of $0.18 per share, vesting monthly over thirty six month period. &lt;font style="letter-spacing: -0.1pt"&gt;The&#13;aggregate fair value of the grant was estimated at $45,000, or $0.18 per option, using the Black-Scholes Option Pricing Model with&#13;weighted average assumptions as follows: a risk free interest rate of 1.95%, a dividend yield of 0%, an expected volatility of&#13;199.0%, and an expected life of 10 years. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;On May 8, 2012, the Company granted 250,000&#13;stock options to a consultant at an exercise price of $0.17 per share, vesting monthly over twelve month period. &lt;font style="letter-spacing: -0.1pt"&gt;The&#13;aggregate fair value of the grant was estimated at $40,000, or $0.17 per option, using the Black-Scholes Option Pricing Model with&#13;weighted average assumptions as follows: a risk free interest rate of 1.71%, a dividend yield of 0%, an expected volatility of&#13;199.0%, and an expected life of 10 years. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;The&#13;expensed portion of the value of the vesting options during the three months ended March 31, 2013 was $29,894 (March 31, 2012 -&#13;$43,482) which was recorded as stock based consulting and management fees. During the period, stock-based consulting and management&#13;fees also includes share based compensation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&lt;b&gt;Share&#13;purchase options&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;A&#13;summary of the Company&amp;#146;s stock options as of March 31, 2013 and changes during the period is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Options&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Life&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,278,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;6.85&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;500,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;0.17&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;9.35&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;(250,000)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;0.35&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,528,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;6.05&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled/Forfeited&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,528,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;5.80&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;At&#13;March 31, 2013, the intrinsic value of the vested options was equal to $nil (December 31, 2012 - $nil).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;A&#13;summary of the status of the Company&amp;#146;s unvested options as of December 31, 2012 is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Shares&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Grant-Date&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Unvested, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;379,575&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Granted&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Vested&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;(171,336)&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;0.18&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Unvested, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;208,239&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.17&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;u&gt;Share Purchase Warrants&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;March, 2012, the Company issued 366,668 share purchase warrants to acquire an equivalent number of common shares of the Company,&#13;at an exercise price of $0.40 per share for an exercise period of up to two years from the issuance date. The warrants were issued&#13;pursuant to the private placement of $110,000 and included within equity. The fair value of these warrants was determined to be&#13;$5,133, using the Black-Scholes Option Pricing Model with an expected life of 2 years, a risk free interest rate of 0.37%, a dividend&#13;yield of 0%, and an expected volatility of 63%.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;April, 2012, the Company issued 1,150,000 share purchase warrants to acquire an equivalent number of common shares of the Company,&#13;at an exercise price of $0.40 per share for an exercise period of up to two years from the issuance date. The warrants were issued&#13;pursuant to a private placement and included within equity. The fair value of these warrants was determined to be $123,000, using&#13;the Black-Scholes Option Pricing Model with an expected life of 2 years, a risk free interest rate of 0.27%, a dividend yield of&#13;0%, and an expected volatility of 146.6%.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;October, 2012, the Company issued 3,000,000 share purchase warrants to acquire an equivalent number of common shares of the Company,&#13;at an exercise price of $0.25 per share for an exercise period of up to four years from the issuance date. The warrants were issued&#13;pursuant to a convertible debt with price adjustment features. The residual fair value of these warrants was determined to be $300,000&#13;and recognized as a derivative liability. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;December, 2012, the Company issued 1,000,000 share purchase warrants to acquire an equivalent number of common shares of the Company,&#13;at an exercise price of $0.10 per share for an exercise period of up to five years from the issuance date. The warrants were issued&#13;pursuant to a private placement and included within equity. The fair value of these warrants was determined to be $178,000, using&#13;the Black-Scholes Option Pricing Model with an expected life of 5 years, a risk free interest rate of 0.87%, a dividend yield of&#13;0%, and an expected volatility of 199.0%.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;In&#13;March, 2013, the Company issued 3,470,709 share purchase warrants to acquire an equivalent number of common shares of the Company,&#13;at an exercise price of $0.07 per share for an exercise period of up to two years from the issuance date. The warrants were issued&#13;pursuant to a private placement and included within equity. The fair value of these warrants was determined to be $245,000, using&#13;the Black-Scholes Option Pricing Model with an expected life of 2 years, a risk free interest rate of 0.24%, a dividend yield of&#13;0%, and an expected volatility of 131.02%.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"&gt;&lt;font style="letter-spacing: -0.1pt"&gt;A&#13;summary of the Company&amp;#146;s share purchase warrants as of March 31, 2013 and changes during the period is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Life&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; border-top: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;12,106,355&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.56&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.81&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;5,516,668&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.26&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;3.32&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Exercised, cancelled or expired&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(714,400)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;2.33&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,908,623&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.39&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.19&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,470,709&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.07&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.00&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Exercised&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,898,588)&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.06&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Extinguished or expired&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,950,000)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.53&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,530,744&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.32&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.57&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;&lt;u&gt;&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ComputationOfNetCapitalUnderSecuritiesAndExchangeCommissionRegulationTextBlock>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Options&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Life&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,278,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;6.85&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;500,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;0.17&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;9.35&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;(250,000)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;0.35&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,528,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;6.05&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled/Forfeited&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;6,528,000&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 18.8pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;5.80&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <tpiv:UnvestedOptionsTableTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Shares&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Grant-Date&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Unvested, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;379,575&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.18&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Granted&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Vested&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;(171,336)&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;0.18&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Cancelled&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;font style="letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Unvested, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 6.45pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.3pt; padding-left: 5.4pt; text-align: right"&gt;208,239&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 21.95pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.17&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</tpiv:UnvestedOptionsTableTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2013-01-01to2013-03-31">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-top: windowtext 1.5pt solid; border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Life&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: top; border-top: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2011&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;12,106,355&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.56&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: windowtext 1pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.81&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;5,516,668&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.26&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;3.32&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Exercised, cancelled or expired&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(714,400)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;2.33&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 0.5pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, December 31, 2012&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,908,623&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.39&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.19&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Issued&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,470,709&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.07&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.00&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Exercised&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,898,588)&lt;/td&gt;&#13;    &lt;td style="padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.06&lt;/td&gt;&#13;    &lt;td style="padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160; Extinguished or expired&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,950,000)&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;0.53&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold"&gt;Balance, March 31, 2013&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,530,744&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 20.4pt; padding-left: 5.4pt; text-align: right"&gt;$&amp;#160; 0.32&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt solid; padding-right: 23.5pt; padding-left: 5.4pt; text-align: right"&gt;2.57&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
</xbrli:xbrl>
